The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling
Article in Experimental Hematology & Oncology (March 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Experimental Hematology & Oncology (March 2024)
Article in Frontiers in Immunology (November 2023)
Article in Gastro Hep Advances (July 2023)